Bulletin
Investor Alert

Denali Therapeutics Inc.

NAS: DNLI

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 27, 2023, 6:16 p.m.

/zigman2/quotes/200043077/composite

$

32.00

Change

+0.53 +1.68%

Volume

Volume 8,205

Quotes are delayed by 20 min

/zigman2/quotes/200043077/composite

Previous close

$ 30.53

$ 31.47

Change

+0.94 +3.08%

Day low

Day high

$30.53

$31.98

Open

52 week low

52 week high

$20.24

$39.43

Open

Insider Actions for Denali Therapeutics Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/09/2023 Carole Ho
Chief Medical Officer
1,459   Disposition at $28.48 per share. 41,552
01/06/2023 Carole Ho
Chief Medical Officer
1,451   Disposition at $28.67 per share. 41,600
01/05/2023 Ryan J. Watts
President and CEO; Director
4,800   Disposition at $28.44 per share. 136,512
01/05/2023 Steve E. Krognes
Director
2,970   Disposition at $28.44 per share. 84,466
01/05/2023 Alexander O. Schuth
COFO and Secretary
2,636   Disposition at $28.44 per share. 74,967
01/05/2023 Carole Ho
Chief Medical Officer
2,636   Disposition at $28.44 per share. 74,967
01/04/2023 Ryan J. Watts
President and CEO; Director
5,029   Disposition at $28.73 per share. 144,483
01/04/2023 Alexander O. Schuth
COFO and Secretary
2,912   Disposition at $28.7 per share. 83,574
01/04/2023 Alexander O. Schuth
COFO and Secretary
2,912   Disposition at $28.7 per share. 83,574
01/04/2023 Carole Ho
Chief Medical Officer
2,913   Disposition at $28.69 per share. 83,573
01/03/2023 Ryan J. Watts
President and CEO; Director
82,240   Award at $0 per share. 0
01/03/2023 Alexander O. Schuth
COFO and Secretary
41,120   Award at $0 per share. 0
01/03/2023 Carole Ho
Chief Medical Officer
41,120   Award at $0 per share. 0
11/23/2022 Marc Tessier-Lavigne
Director
20,000   Disposition at $30.48 per share. 609,600
11/02/2022 Marc Tessier-Lavigne
Director
11,252   Disposition at $30.33 per share. 341,273
11/01/2022 Marc Tessier-Lavigne
Director
8,748   Disposition at $30.2 per share. 264,189
10/07/2022 Alexander O. Schuth
COFO and Secretary
20,000   Derivative/Non-derivative trans. at $0.68 per share. 13,600
09/28/2022 Marc Tessier-Lavigne
Director
4,423   Disposition at $31.08 per share. 137,466
09/28/2022 Marc Tessier-Lavigne
Director
15,577   Disposition at $30.74 per share. 478,836

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
3 Purchases
13 Sales
164,480
69,718
Last 6 months
6 Purchases
22 Sales
229,480
121,951
Last 12 months
18 Purchases
38 Sales
417,486
254,986

Officers and Executives

Dr. Ryan J. Watts
President, Chief Executive Officer & Director
Dr. Alexander O. Schuth
Secretary, Chief Operating & Financial Officer
Dr. Joe Lewcock
Chief Scientific Officer
Dr. Carole Ho
Chief Medical Officer & Head-Development
Dr. Dana Andersen
CTO & Chief Manufacturing Officer
Ms. Katie Peng
Chief Commercial Officer
Mr. Steve E. Krognes
Director
Dr. Laura G. Hansen
Vice President-Investor Relations
Ms. Cindy Dunkle
Chief People Officer
Dr. Chris Walsh
Associate General Counsel
Ms. Erica Kratz
Vice President-Regulatory
Dr. Vicki L. Sato
Non-Executive Chairman
Ms. Nancy A. Thornberry
Independent Director
Mr. Erik C. Harris
Independent Director
Dr. Marc Tessier-Lavigne
Independent Director
Dr. Douglas G. Cole
Independent Director
Mr. Jay T. Flatley
Independent Director
Mr. Robert Taylor Nelsen
Independent Director
Dr. David Paul Schenkein
Independent Director
Mr. Peter S. Klein
Independent Director
Ms. Jennifer E. Cook
Independent Director
Link to MarketWatch's Slice.